echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > [exclusive] a brief analysis of the bidding dynamics in October 2018, and the results of public price negotiation of imported anticancer drugs by the provincial Alliance

    [exclusive] a brief analysis of the bidding dynamics in October 2018, and the results of public price negotiation of imported anticancer drugs by the provincial Alliance

    • Last Update: 2018-11-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In October, the special purchase of anti-cancer drugs imported by the inter provincial alliance completed the negotiation work 14 provinces (regions) such as Shaanxi and Shanxi publicized the results of the joint negotiation respectively For the specific results, please refer to the brief analysis of the main body The small edition summarized the bidding dynamics of drugs in this month (October) for reference (as of November 5): 1 Summary of bidding dynamics of provinces and cities 2 Brief analysis On October 19, 2018, the special purchase of imported anticancer drugs of the inter provincial alliance completed the negotiation work and publicized the results The publicity period is from October 20, 2018 to October 26, 2018 The negotiation results can be viewed on the purchase platforms of 14 alliance provinces In this result, the catalog of successful negotiation, unsuccessful negotiation and undeclared products are published Among them, there are 48 specifications of different enterprises with successful negotiation, 11 unsuccessful ones and 29 undeclared product catalogues In the list of successful price negotiation, the highest price is MSD's pabolizumab injection, the price negotiation result of 100mg / 4mg is 17918 yuan; the lowest price is Baxter's cyclophosphamide for injection, the price negotiation result of 0.2g is 24.18 yuan This month, Shandong Province announced the results of winning the bid for the centralized procurement part and the results of some networking It includes the bidding products (the eighth batch) purchased by medical institutions in East China, and some drugs directly linked to the Internet purchased by anti-cancer drugs in Shandong Province Among them, in the eighth batch, there are 9 varieties of different enterprises in the summary and announcement of the results, while 87 varieties of different enterprises in the part of hanging net are published in the results On October 31, 2018, Hunan Province announced the second round of inter provincial price linkage results of drugs The product specifications of 7799 enterprises with different varieties were published in the linkage results and officially implemented on December 1, 2018 Among the linkage results, 2491 product specifications of different enterprises have changed on the basis of the original Hunan online price, and all of them have been reduced in price 5308 product specifications are consistent with the original online price without any change If you need to know more about the bidding dynamics, please remember to pay attention to our bid information inquiry of pharmaceutical intelligent drugs Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.